Molecular Endocrinology, Vol 10, 1549-1560, Copyright © 1996 by Endocrine Society

ARTICLES

Characterization of the human mineralocorticoid receptor gene 5'- regulatory region: evidence for differential hormonal regulation of two alternative promoters via nonclassical mechanisms

MC Zennaro, D Le Menuet and M Lombes
INSERM U 246, Institut Federatif de Recherche Cellules Epitheliales Faculte de Medecine Xavier Bichat, Paris, France.

The mineralocorticoid receptor (MR) is a ligand-dependent transcription factor involved in the regulation of sodium homeostasis. Two distinct mRNA isoforms of the human MR (hMR) differing in their untranslated 5'- ends have recently been identified, suggesting the existence of alternative promoters. To eludicate the regulatory mechanisms controlling hMR gene expression, we have isolated and characterized approximately 15 kb of hMR 5'-flanking region. Various deletion mutants of regions located immediately upstream of the untranslated exons 1 alpha and 1 beta (P1: 1 kb and P2: 1.7 kb, respectively) were inserted into a luciferase reporter gene and used in transient transfection experiments in CV-1 and human differentiated renal H5 cells. Both regions were shown to possess significant functional promoter activity, more pronounced in renal cells, although P1 directed higher levels of basal transcription. Cotransfection experiments with hMR or human glucocorticoid receptor (hGR) revealed that, while both promoters were glucocorticoid inducible, only the distal P2 promoter was stimulated by aldosterone in a dose- and hMR-dependent manner. Furthermore, we demonstrate that hMR and hGR are able to synergistically activate the P2 promoter, consistent with cooperativity between the two transduction pathways. Mineralocorticoid induction was localized to a region between -318 and +123 bp of P2. This region does not contain any consensus hormone responsive element, and direct binding of hMR to this DNA sequence was not observed, indicating that mineralocorticoid-induced transcriptional enhancement is mediated by nonclassical mechanisms. On the other hand, Sp1 and AP-2 bind to definite sequences on both promoters, suggesting that they represent important regulators of hMR promoter activity. Our results indicate that hMR gene expression is under the control of complex regulatory mechanisms involving alternative promoters and differential hormonal control, which might allow tissue-specific modulation of aldosterone action.

This article has been cited by other articles:

				L. Pascual-Le Tallec and M. Lombes The Mineralocorticoid Receptor: A Journey Exploring Its Diversity and Specificity of Action Mol. Endocrinol., September 1, 2005; 19(9): 2211 - 2221. [Abstract] [Full Text] [PDF]

				A. I Freeman, H. L Munn, V. Lyons, A. Dammermann, J. R Seckl, and K. E Chapman Glucocorticoid down-regulation of rat glucocorticoid receptor does not involve differential promoter regulation J. Endocrinol., November 1, 2004; 183(2): 365 - 374. [Abstract] [Full Text] [PDF]

				A.-M. Samuelsson, I. Ohrn, J. Dahlgren, E. Eriksson, B. Angelin, B. Folkow, and A. Holmang Prenatal Exposure to Interleukin-6 Results in Hypertension and Increased Hypothalamic-Pituitary-Adrenal Axis Activity in Adult Rats Endocrinology, November 1, 2004; 145(11): 4897 - 4911. [Abstract] [Full Text] [PDF]

				P. Sartorato, F. Cluzeaud, J. Fagart, S. Viengchareun, M. Lombes, and M.-C. Zennaro New Naturally Occurring Missense Mutations of the Human Mineralocorticoid Receptor Disclose Important Residues Involved in Dynamic Interactions with Deoxyribonucleic Acid, Intracellular Trafficking, and Ligand Binding Mol. Endocrinol., September 1, 2004; 18(9): 2151 - 2165. [Abstract] [Full Text] [PDF]

				L. Pascual-Le Tallec, O. Kirsh, M.-C. Lecomte, S. Viengchareun, M.-C. Zennaro, A. Dejean, and M. Lombes Protein Inhibitor of Activated Signal Transducer and Activator of Transcription 1 Interacts with the N-Terminal Domain of Mineralocorticoid Receptor and Represses Its Transcriptional Activity: Implication of Small Ubiquitin-Related Modifier 1 Modification Mol. Endocrinol., December 1, 2003; 17(12): 2529 - 2542. [Abstract] [Full Text] [PDF]

				P. Sartorato, A.-L. Lapeyraque, D. Armanini, U. Kuhnle, Y. Khaldi, R. Salomon, V. Abadie, E. Di Battista, A. Naselli, A. Racine, et al. Different Inactivating Mutations of the Mineralocorticoid Receptor in Fourteen Families Affected by Type I Pseudohypoaldosteronism J. Clin. Endocrinol. Metab., June 1, 2003; 88(6): 2508 - 2517. [Abstract] [Full Text] [PDF]

				C. E. Deppe, P. J. Heering, S. Viengchareun, B. Grabensee, N. Farman, and M. Lombes Cyclosporine A and FK506 Inhibit Transcriptional Activity of the Human Mineralocorticoid Receptor: A Cell-Based Model to Investigate Partial Aldosterone Resistance in Kidney Transplantation Endocrinology, May 1, 2002; 143(5): 1932 - 1941. [Abstract] [Full Text] [PDF]

				A. R. Nawrocki, C. E. Goldring, R. M. Kostadinova, F. J. Frey, and B. M. Frey In Vivo Footprinting of the Human 11beta -Hydroxysteroid Dehydrogenase Type 2 Promoter. EVIDENCE FOR CELL-SPECIFIC REGULATION BY Sp1 AND Sp3 J. Biol. Chem., April 19, 2002; 277(17): 14647 - 14656. [Abstract] [Full Text] [PDF]

				D. Le Menuet, R. Isnard, M. Bichara, S. Viengchareun, M. Muffat-Joly, F. Walker, M.-C. Zennaro, and M. Lombes Alteration of Cardiac and Renal Functions in Transgenic Mice Overexpressing Human Mineralocorticoid Receptor J. Biol. Chem., October 12, 2001; 276(42): 38911 - 38920. [Abstract] [Full Text] [PDF]

				M.-C. Zennaro, A. Souque, S. Viengchareun, E. Poisson, and M. Lombes A New Human MR Splice Variant Is a Ligand-Independent Transactivator Modulating Corticosteroid Action Mol. Endocrinol., September 1, 2001; 15(9): 1586 - 1598. [Abstract] [Full Text] [PDF]

				T. Ikeda, M. Kasai, M. Utsuyama, and K. Hirokawa Determination of Three Isoforms of the Receptor Activator of Nuclear Factor-{{kappa}}B Ligand and Their Differential Expression in Bone and Thymus Endocrinology, April 1, 2001; 142(4): 1419 - 1426. [Abstract] [Full Text]

				P. Penfornis, S. Viengchareun, D. Le Menuet, F. Cluzeaud, M.-C. Zennaro, and M. Lombes The mineralocorticoid receptor mediates aldosterone-induced differentiation of T37i cells into brown adipocytes Am J Physiol Endocrinol Metab, August 1, 2000; 279(2): E386 - E394. [Abstract] [Full Text] [PDF]

				D. Le Menuet, S. Viengchareun, P. Penfornis, F. Walker, M.-C. Zennaro, and M. Lombes Targeted Oncogenesis Reveals a Distinct Tissue-specific Utilization of Alternative Promoters of the Human Mineralocorticoid Receptor Gene in Transgenic Mice J. Biol. Chem., March 10, 2000; 275(11): 7878 - 7886. [Abstract] [Full Text] [PDF]

				J. P. Herman, S. J. Watson, and R. L. Spencer Defense of Adrenocorticosteroid Receptor Expression in Rat Hippocampus: Effects of Stress and Strain Endocrinology, September 1, 1999; 140(9): 3981 - 3991. [Abstract] [Full Text]

				D. M. Vazquez, J. F. Lopez, M. I. Morano, S. P. Kwak, S. J. Watson, and H. Akil {alpha}, {beta}, and {gamma} Mineralocorticoid Receptor Messenger Ribonucleic Acid Splice Variants: Differential Expression and Rapid Regulation in the Developing Hippocampus Endocrinology, July 1, 1998; 139(7): 3165 - 3177. [Abstract] [Full Text] [PDF]

				M.-C. Zennaro, N. Farman, J.-P. Bonvalet, and M. Lombes Tissue-Specific Expression of {alpha} and {beta} Messenger Ribonucleic Acid Isoforms of the Human Mineralocorticoid Receptor in Normal and Pathological States J. Clin. Endocrinol. Metab., May 1, 1997; 82(5): 1345 - 1352. [Abstract] [Full Text] [PDF]